Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 10:10:100255.
doi: 10.1016/j.prdoa.2024.100255. eCollection 2024.

CRPD frontiers in movement disorders Therapeutics: From evidence to treatment and applications: Addressing Patients' Needs in the Management of the Ataxias

Affiliations

CRPD frontiers in movement disorders Therapeutics: From evidence to treatment and applications: Addressing Patients' Needs in the Management of the Ataxias

Susan L Perlman. Clin Park Relat Disord. .

Abstract

The genetic ataxias have no cures and no proven ways to delay progression (no disease-modifying therapies). The acquired ataxias may have treatments that address the underlying cause and may slow or stop progression, but will not reverse damage already sustained. The idiopathic ataxias (of unknown genetic or acquired cause) also have no proven disease-modifying therapies. However, for all patients with ataxia of any cause, there is always something that can be done to improve quality of life-treat associated symptoms, provide information and resources, counsel patient and family, help with insurance and disability concerns, be available to listen and answer the many questions they will have.

Keywords: Ataxia; Diagnosis; Multidisciplinary; Research; Treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Lin C.R., Kuo S.H. Ataxias: Hereditary, Acquired, and Reversible Etiologies. Semin. Neurol. 2023;43(1):48–64. - PMC - PubMed
    1. Radmard S., Zesiewicz T.A., Kuo S.H. Evaluation of Cerebellar Ataxic Patients. Neurol. Clin. 2023;41(1):21–44. - PMC - PubMed
    1. Roberts L.J., et al. Overview of the Clinical Approach to Individuals With Cerebellar Ataxia and Neuropathy. Neurol Genet. 2022;8(5):e200021. - PMC - PubMed
    1. Hadjivassiliou M., et al. Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients. J. Neurol. Neurosurg. Psychiatry. 2017;88(4):301–309. - PubMed
    1. Wenning G.K., et al. The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy. Mov. Disord. 2022;37(6):1131–1148. - PMC - PubMed